Stop muzzling the 1%: The wealthy have a right to free speech - and democracy needs billionaires
Bashing the rich won't fix inequality - it simply gives power to elites who already control the agenda.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesBashing the rich won't fix inequality - it simply gives power to elites who already control the agenda.
Consumer staples, long seen as a safety play when tech stocks sell off, are now among the riskier bets on Wall Street.
The healthcare that patients get before and after a stroke depends largely on the insurance they have - highlighting the differences between Medicare Advan...
The bank said rising volumes, tighter market structure and early institutional engagement are pushing prediction markets beyond their gambling roots toward...
Novo Nordisk's study showing a new drug wasn't as good as a rival's led one sell-side analyst to downgrade the stock for the first time in five years.
Ford recalls over 412,000 Explorer vehicles due to suspension issue
The luxury car market in China is set to grow significantly from US$ 207.19 billion in 2025 to US$ 355.46 billion by 2033, with a CAGR of 6.98%. This growt...
These top brands are undervalued.
This biotech powerhouse could maintain its strength for the long term.
Paramount submits higher offer for Warner Bros Discovery in bid to block Netflix, source says
Ford to recall about 413,000 SUVs in US over potential loss of steering control, NHTSA says
UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo NordiskIn a pl...